The large-scale proteome program from the CPTAC (National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium) enabled us to analyze TWF2 at the protein level, in addition to its transcription. This evidence concerns the gene TWF2 and neoplasm.